Glaxo's ViiV Healthcare Submits New Drug Application For HIV Treatment
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said ViiV Healthcare is seeking US Food & Drug Administration approval for the investigational, monthly, injectable, two-drug regimen of Read More